The digitization of pharmaceutical production is no longer a future vision but a necessity.

Shortage of skilled workers, rising energy costs, and strict regulatory requirements are forcing pharmaceutical companies to optimize their production processes. Many companies, however, struggle with outdated, isolated systems that lead to inefficient manual processes and media disruptions. These gaps cost time, money, and increase the risk of compliance violations. A comprehensive digitalization of processes can help here and make production more efficient, safer, and more transparent.

This is where the modular digitalization solution from eurogard GmbH and EST Edelstahlbau Tannroda GmbH comes into play. It offers a flexible, GMP-compliant, and verifiable IIoT architecture that optimizes existing structures and lays the foundation for future-proof and transparent production.

Status quo & existing gaps in automation

Many pharmaceutical companies face the challenge of integrating their production facilities, stainless steel tanks, and critical processes into a digital infrastructure. Systems currently in use are often isolated, with sensor technology not fully digitalized, so manual documentation processes are still necessary. These are not only time-consuming but also prone to errors and hinder holistic process monitoring. Particularly problematic is the lack of real-time monitoring, which favors unplanned downtimes, formulation deviations, batch errors, and inefficient maintenance strategies.

Previous digitalization approaches are often associated with high costs and lengthy implementation phases. Additionally, traditional SCADA or MES systems are often monolithic and inflexible. The digitalization solution from eurogard and EST follows a new approach: it is modular, scalable, retrofittable for existing systems, and optimized for the specific requirements of pharmaceutical production.

The solution: Modular digitalization for stainless steel tanks and machines

The cooperation between eurogard and EST Edelstahlbau combines two core competencies: EST has decades of experience in stainless steel and plant construction and understands the requirements of pharmaceutical companies, while eurogard, as a specialist for IIoT technologies and monitoring systems, drives digital transformation forward.

The system is based on three central components:

1. m2v platform: Central data management and visualization solution. Storage and analysis of all relevant machine parameters with customizable dashboards and automated reports. The digital record enables seamless documentation of all production and maintenance processes.
2. in.Hub Gateway: Edge device for connecting stainless steel tanks to the m2v platform. Real-time collection of relevant process data (pressure, temperature, fill level) and secure transmission.
3. EST approach tanks: Stainless steel tanks with state-of-the-art sensors and process logic as a digital twin for continuous monitoring and process analysis.

Through this combination, seamless interfaces are created between OT (Operational Technology) and IT (enterprise systems such as ERP or MES). Production data are not only collected but also directly integrated into operational decision-making processes. The GMP-compliant, verifiable software and hardware ensure that all regulatory requirements are met.

Process and planning security through data transparency

The digitalization of pharmaceutical production is no longer a future vision but a necessity to remain competitive. The modular digitalization solution from eurogard and EST offers an economically sensible and regulation-compliant way to close existing automation gaps and achieve sustainable process optimization.

A pharmaceutical manufacturer using mobile approach tanks for the production and processing of active pharmaceutical ingredients can achieve significant improvements by implementing the modular digitalization solution. Without this solution, process parameters such as pressure and temperature control within a formulation can only be managed through manual interventions and checked via regular inspections. This often leads to fluctuations in operating parameters going unnoticed, resulting in formulation deviations that impair product quality and cause batch errors.

With the modular digitalization solution, all parameters can be monitored in real time and evaluated on the m2v platform. For example, if an unusual pressure fluctuation is detected in a tank, the system can automatically send an alarm to the maintenance team before a limit is exceeded. Early inspection allows potential causes, such as an emerging leak, to be identified and addressed in time before production is interrupted. Furthermore, the entire process is seamlessly documented in the digital record to demonstrate formulation compliance or to trace unusable batches according to regulatory requirements. This proactive approach not only increases operational safety but also significantly reduces unforeseen costs and downtime.

Conclusion & outlook

The digitalization of pharmaceutical production is now of utmost priority to remain competitive globally. The modular digitalization solution from eurogard and EST offers an economically viable and regulation-compliant way to close automation gaps and achieve sustainable process optimization.

Thanks to easier GMP validation, real-time data analysis, and seamless OT-IT integration, companies benefit from higher efficiency, safer production processes, and better planning. The solution is flexibly scalable and can be implemented in both new and existing production environments.

Companies looking to make their processes more efficient and safer should act now. The modular architecture of the digitalization solution allows for step-by-step implementation, so initial economic benefits can be seen quickly.

Visit us at the lounges in Karlsruhe and experience our solution live in action! Schedule an appointment now for personalized consultation.